W
RPRX icon

WealthCollab’s Royalty Pharma RPRX Stock Holding History

WealthCollab’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.16K Hold
45
– – ﹤0.01% 829
2025
Q4 		$1.74K Hold
45
– – ﹤0.01% 909
2025
Q3 		$1.59K Buy
+45
New +$1.63K ﹤0.01% 868
2024
Q4 		– Sell
-69
Closed -$1.95K – 928
2024
Q3 		$1.95K Buy
+69
New +$1.91K ﹤0.01% 777

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

WealthCollab's RPRX Position: Q1 2026 in Review

WealthCollab held its Royalty Pharma (RPRX) position steady in Q1 2026 at 45 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #829.

WealthCollab first reported a position in RPRX in Q3 2024 and has held it in 4 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • WealthCollab held 45 shares of Royalty Pharma worth $2.16K as of Q1 2026.
  • WealthCollab left its Royalty Pharma share count unchanged in Q1 2026.
  • Royalty Pharma made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #829 holding.
  • WealthCollab first reported a position in Royalty Pharma in Q3 2024 and has held it in 4 quarters since.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.